AVITA Medical
RCEL
#9122
Rank
โ‚น10.80 B
Marketcap
โ‚น354.44
Share price
12.72%
Change (1 day)
-53.10%
Change (1 year)
Categories

P/E ratio for AVITA Medical (RCEL)

P/E ratio as of January 2026 (TTM): -2.15

According to AVITA Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.1547. At the end of 2024 the company had a P/E ratio of -5.36.

P/E ratio history for AVITA Medical from 2020 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-5.36
2021-11.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Novocure
NVCR
-8.47 293.19% Jersey
Novavax
NVAX
3.78-275.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-0.1771-91.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-2.69 25.01%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.